$ARCT

Arcturus Therapeutics Holdings Inc

  • NASDAQ/NMS (GLOBAL MARKET)
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$55.38 ▲0.435%

Extented Hours

VOLUME

701,668

DAY RANGE

50.01 - 56.56

52 WEEK

8.51 - 129.71

Echofin Members Consensus

profile
@Benlax #droscrew Join team
recently

$ARKG shows the reflexivity... $6.9B AUM (< $500M at year end) with $3B of flows THIS QUARTER. It holds 5 stocks < $500M cap (a 0.25% weight in $PSTI is ~10% of the company and ~20% of $ARCT. YTD returns vs how much they own of each (only 5 stocks with negative returns).

profile
@Benlax #droscrew Join team
recently

The most interesting buys disclosed by hedge funds in the last 5 days: $FSR tweeted already $SKLZ $NET $APPN $TRIP $MSTR $CDLX $ARCT $ATRA $IRWD $CHRS $GKOS $ZIOP $OXFD $MGLN Tweeted. $NVUS

profile
@FUZZJP #ivtrades Join team
recently

BTO ARCT 65C 1/15/21 @3

profile
@FUZZJP #ivtrades Join team
recently

$ARCT and $FLGT were on my scanner last week and I didn't think that the action was compelling enough lol

profile
@ashy2classy #droscrew Join team
recently

Business Insider: Arcturus Therapeutics plummets 53% after analyst downgrades following COVID-19 vaccine trial updates (ARCT)

profile
@Navneet #droscrew Join team
recently

whats $arct why it got dumped

profile
@Navneet #droscrew Join team
recently

im 5 says $arct

profile
@Navneet #droscrew Join team
recently

have a look on $arct

profile
@DaveDixon #CoreTrader Join team
recently

US Market US closed lower yesterday, amid concerns over economic recovery and as hopes for additional stimulus faded. Arcturus Therapeutics Holdings plunged 54.2%, as the company provided a disappointing update on its Covid-19 vaccine candidate, ARCT-021. Target lost 0.8%, after the company sold its Dermstore operation to THG Holdings for a cash consideration of $350.0 million. On the flipside, Snap jumped 6.2%, after a top broker raised its target price on the stock to $70.0 per share from $47.0 per share. Continental Resources advanced 1.7%, after a top broker upgraded its rating on the stock to ‘Overweight’ from ‘Sector Weight’. Bausch Health added 0.3%, after the drugmaker announced that it would pay down another $275.0 million in debt on 31 December 2020. Boeing rose 0.1%, as the airline operator resumed passenger flights in the US after a two-year halt. The S&P 500 slipped 0.2%, to settle at 3,727.0. The DJIA fell 0.2%, to settle at 30,335.7, while the NASDAQ shed 0.4%, to close at 12,850.2. .

profile
@Pyrognosis #droscrew Join team
recently

Stocktwits all buying ARCT now

profile
@Pyrognosis #droscrew Join team
recently

like $ARCT lol

profile
@Pyrognosis #droscrew Join team
recently

$ARCT wow, some real bag holders there

JC
@JCrow #StockTraders.NET Join team
recently

stopped out $ARCT

JC
@JCrow #StockTraders.NET Join team
recently

Long $ARCT - $113

profile
@dros #droscrew Join team
recently

846 $ARCT 18DEC20 $80 Cs trade 5.00

profile
@dros #droscrew Join team
recently

846 $ARCT 18DEC20 $80 Cs trade 5.00

profile
@dros #droscrew Join team
recently

$ARCT exploding

profile
@Neptune5045 #StockTraders.NET Join team
recently

$ARCT as well

profile
@PradeepB #droscrew Join team
recently

sold arct for profits

profile
@viking #StockTraders.NET Join team
recently

covered ARCT for +1 but terrible trade

profile
@viking #StockTraders.NET Join team
recently

SS ARCT 53.74 will add

profile

added short to $ARCT position from Monday.

profile

added short $ARCT

profile

started short $ARCT small - target under 45

profile

done with $ARCT - great trade

profile

1/2 ARCT sold so far

profile

added $ARCT long

NM
@Nmccorry #StockTraders.NET Join team
recently

What is the target for $ARCT?

profile

Long some ARCT

GO
@GOUAGHOU #StockTraders.NET Join team
recently

Thank you guys for all the trades you shared. Thank you MT for the $ARCT trade. As I am going through the trades, I was wondering what kind of play was ARCT?

profile

we played ARCT , BIDU, BLNK, INO NKLA

Key Metrics

Market Cap

1.33 B

Beta

0.45

Avg. Volume

1.08 M

Shares Outstanding

24.49 M

Yield

0%

Public Float

0

Next Earnings Date

2021-03-11

Next Dividend Date

Company Information

Website:

HQ: ,

Related News

  • MarketScreener

    Arcturus Therapeutics : Acquires Exclusive License to mRNA Manufacturing Technology from Alexion Pharmaceuticals | MarketScreener

    22 Feb 2021, 13:06
  • Business Wire

    Arcturus Therapeutics Acquires Exclusive License to mRNA Manufacturing Technology from Alexion Pharmaceuticals

    22 Feb 2021, 13:00
  • 24/7 Wall street

    Arcturus Therapeutics, Chesapeake Energy, Square, and More Wednesday Afternoon Analyst Calls

    17 Feb 2021, 19:20
  • AmpBioResearch

    Biopharma Daily Stock Updates - 01/04/20

    05 Jan 2021, 00:20
  • Business Wire

    Arcturus Therapeutics Receives FDA Allowance to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate in the United States

    04 Jan 2021, 12:01